(Q74690241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Is epoetin alfa a treatment option for chemotherapy-related anemia in children? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Münevver Büyükpamukçu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ali Varan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Tezer Kutluk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Canan Akyüz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

455-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

Erythropoietin for anaemia in cancer patients

12 November 2019

cites work

1 reference

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

21 January 2018

1 reference

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

21 January 2018

1 reference

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

21 January 2018

1 reference

Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer.

21 January 2018

1 reference

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Treatment with recombinant human erythropoietin in children with malignancies.

21 January 2018

1 reference

Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: a case-control study.

21 January 2018

1 reference

Recombinant human erythropoietin treatment for chemotherapy-related anemia in children

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MPO.10185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12203663%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference